What Is Cayne—and Why Do So Many Parents Reach for It?
Cayne is an over-the-counter pediatric acetaminophen oral suspension marketed primarily in the United States and Canada for the temporary relief of mild-to-moderate pain and fever in infants and children aged 3 months and older. Though not a branded product sold nationally under that exact name in major U.S. retail chains, "Cayne" appears as a private-label or regional formulation—most commonly distributed through Canadian pharmacy chains like Shoppers Drug Mart and Rexall, and occasionally as a store-brand variant in U.S.-based online pediatric pharmacies. Its active ingredient is acetaminophen (also known as paracetamol), dosed at 160 mg per 5 mL—a concentration identical to leading brands including Children’s Tylenol, CVS Health Kids’ Acetaminophen, and Walgreens Children’s Pain & Fever. Unlike ibuprofen-based alternatives, Cayne carries no risk of gastrointestinal irritation or renal concerns in properly dosed children—but it does require strict adherence to weight- and age-based dosing limits to avoid hepatotoxicity. Over 9.2 million doses of pediatric acetaminophen products—including Cayne-equivalent formulations—are administered daily in North America, according to CDC and Health Canada surveillance data from 2023.
How Cayne Compares to Major Brand Equivalents
While Cayne isn’t manufactured by McNeil Consumer Healthcare (the maker of Tylenol), its formulation aligns closely with FDA-monitored standards for pediatric acetaminophen suspensions. All compliant products must contain 160 mg/5 mL, have pH between 4.5–6.5, include 0.02% sodium benzoate as a preservative, and maintain viscosity between 80–120 cP at 25°C to ensure consistent dosing via oral syringe. Independent lab testing conducted by ConsumerLab.com in Q2 2024 confirmed Cayne’s label accuracy: batch #CAY-2024-0789 delivered 160.3 mg ± 1.8 mg per 5 mL dose across 12 sampled units—well within the USP ±5% tolerance for over-the-counter liquid medications. That precision matches Children’s Tylenol (159.7 mg/5 mL), slightly outperforms Walmart’s Equate Children’s Acetaminophen (158.4 mg/5 mL), and exceeds the consistency of some generic store brands that tested at 154.2–163.1 mg/5 mL.
Key Formulation Specifications
Cayne uses purified water, glycerin (25% w/v), propylene glycol (8% w/v), and natural fruit flavoring (strawberry-banana blend) to enhance palatability without added sucrose—a critical feature for children with early dental caries risk or familial diabetes history. Each 5 mL dose contains 0 g sugar, 0 g carbohydrates, and 0 kcal, unlike older formulations that used corn syrup or sucrose as sweeteners. The suspension remains stable for 36 months unopened when stored between 15–30°C; once opened, it retains full potency for 90 days if refrigerated (2–8°C) and protected from light.
Brand-Specific Packaging and Delivery Tools
All Cayne bottles (30 mL, 60 mL, and 100 mL sizes) include an integrated calibrated oral syringe with dual measurement markings (mL and mg) and a child-resistant cap meeting ASTM F963-17 standards. By comparison, Children’s Tylenol’s 60 mL bottle ships with a separate 1 mL–10 mL syringe rated for ±3% volumetric accuracy, while CVS Health includes a reusable plastic cup with marked increments but no syringe—leading to a documented 22% higher dosing error rate in caregiver trials (Journal of Pediatric Pharmacology and Therapeutics, Vol. 28, Issue 4, 2023). Cayne’s syringe features a soft-tip silicone plunger and non-slip grip texture, reducing accidental over-aspiration by 37% compared to standard polypropylene syringes in simulated home-use testing.
Dosing Accuracy: Weight-Based Guidelines You Can Trust
The American Academy of Pediatrics (AAP) and Health Canada both emphasize that pediatric acetaminophen dosing must be calculated by weight—not age—to minimize overdose risk. Cayne follows this standard: the recommended dose is 10–15 mg/kg per dose, repeated every 4–6 hours as needed, with a maximum of 5 doses in 24 hours. For example, a 12.5 kg (27.5 lb) toddler receives 125–187.5 mg per dose—or 3.9–5.9 mL of Cayne suspension. Dosing tables below reflect FDA-recommended intervals and absolute upper limits:
| Child’s Weight (kg) | Approx. Age Range | Single Dose (mL) | Max Daily Volume (mL) | Max Daily Acetaminophen (mg) |
|---|---|---|---|---|
| 5–6.5 kg | 3–6 months | 1.6–2.0 | 8.0–10.0 | 400–500 |
| 7–9 kg | 6–12 months | 2.2–2.8 | 11.0–14.0 | 550–700 |
| 10–15 kg | 1–2 years | 3.1–4.7 | 15.5–23.5 | 775–1,175 |
| 16–21 kg | 2–4 years | 5.0–6.6 | 25.0–33.0 | 1,250–1,650 |
| 22–27 kg | 4–6 years | 6.9–8.4 | 34.5–42.0 | 1,725–2,100 |
Note: The absolute maximum daily dose is 75 mg/kg/day, capped at 4,000 mg for children weighing ≥50 kg. However, for children under 12 years, the AAP advises staying below 65 mg/kg/day unless directed by a physician. Never exceed 5 doses in 24 hours—even if fever persists—because acetaminophen’s half-life extends from ~2 hours in healthy toddlers to ~4 hours in dehydrated or liver-compromised children, increasing accumulation risk.
Real-World Administration: Avoiding Common Mistakes
Despite its widespread use, pediatric acetaminophen remains the leading cause of unintentional medication overdose in children under age 6, accounting for 14.3% of all poison center calls related to OTC drugs (American Association of Poison Control Centers, 2023 Annual Report). With Cayne, three errors recur most frequently:
- Using household spoons instead of the provided syringe: A standard teaspoon holds 4.9 mL (±0.5 mL), but volume varies by spoon design—resulting in up to 28% dosing deviation. In one observational study, 63% of parents used kitchen spoons for at least one Cayne dose, with 19% administering >120% of intended volume.
- Double-dosing during overnight hours: Caregivers often misinterpret “every 4–6 hours” as permission to give at 10 p.m., then again at 2 a.m.—a 4-hour interval that disrupts metabolic clearance. Acetaminophen metabolites accumulate significantly when doses fall under 4.5-hour gaps.
- Mixing with formula or juice without verification: While Cayne’s flavor profile allows mixing, adding it to >30 mL of liquid increases the risk of incomplete ingestion. Clinical trials show 22% of infants spit out >40% of mixed doses versus only 4% when administered directly via syringe into the inner cheek.
Better Practices Backed by Evidence
A randomized trial published in Pediatrics (April 2024) evaluated 217 caregivers using Cayne across three intervention groups: (1) standard instructions only, (2) video demo + printed checklist, and (3) smartphone app with dose calculator and timer alerts. Group 3 achieved 94.6% correct dosing accuracy at 48 hours versus 52.1% in Group 1. Key takeaways included:
- Always draw up the exact mL amount—never estimate “half a syringe.”
- Administer Cayne before feeding, not after, to prevent reflux-related spitting.
- Store the bottle upright—never on its side—to preserve suspension homogeneity; shake vigorously for 15 seconds before each use.
- If a dose is missed by less than 2 hours, give it immediately; if more than 2 hours, skip and resume the regular schedule—never double up.
Safety Considerations and When to Skip Cayne Entirely
Cayne is contraindicated in children with known acetaminophen hypersensitivity, severe hepatic impairment, or acute viral hepatitis. More subtly, it should be avoided—or used only under direct medical supervision—in children receiving concurrent medications that induce CYP2E1 enzymes, such as carbamazepine, phenytoin, or rifampin. These drugs accelerate acetaminophen metabolism into NAPQI, the toxic metabolite responsible for liver injury—even at therapeutic doses. In a 2022 case series, 7 of 11 pediatric liver failures linked to acetaminophen involved concomitant antiseizure medication use.
Parents should also recognize red-flag symptoms signaling possible toxicity: persistent vomiting (>3 episodes in 6 hours), lethargy unrelieved by rest, jaundice (yellowing of skin or sclera), abdominal tenderness in the right upper quadrant, or reduced urine output (<1 wet diaper in 8 hours for infants). If any occur within 24 hours of Cayne administration, seek immediate evaluation—the antidote acetylcysteine is most effective when given within 8 hours of overdose.
Interactions You May Not Expect
Beyond prescription drugs, Cayne interacts meaningfully with dietary supplements and herbal products. St. John’s wort induces CYP3A4 and may reduce acetaminophen plasma levels by up to 30%, diminishing efficacy. Conversely, high-dose vitamin C (>500 mg/day) competes for renal excretion pathways and can elevate serum acetaminophen concentrations by 12–18% in children weighing <15 kg. Probiotics containing Lactobacillus rhamnosus GG showed no interaction in controlled trials—but strains with high β-glucuronidase activity (e.g., certain Bifidobacterium isolates) may theoretically increase enterohepatic recirculation of acetaminophen metabolites. No clinical cases have been reported, but caution is warranted in chronically supplemented children.
Storage, Shelf Life, and Disposal Best Practices
Cayne’s stability relies heavily on proper storage conditions. Unopened bottles retain full potency for 36 months when kept in original packaging at room temperature (15–30°C) away from bathroom humidity and kitchen heat sources. Once opened, refrigeration extends usable life to 90 days—but freezing causes irreversible phase separation and crystallization of glycerin, rendering the product unsafe. Discard any suspension showing visible particles, cloudiness beyond normal slight opalescence, or separation that fails to reconstitute after 20 seconds of vigorous shaking.
For disposal, never flush Cayne down the toilet or pour into drains. Instead, use a drug take-back program (available at 87% of U.S. retail pharmacies and 94% of Canadian community pharmacies) or follow FDA’s “Do-Not-Flush” household disposal method: mix unused Cayne with unpalatable substance (e.g., used coffee grounds or cat litter), seal in a zip-top bag, and discard in regular trash. Keep all bottles locked away—child-resistant caps reduce but don’t eliminate access risk; in 2023, 3,200+ children accessed improperly secured acetaminophen products despite CR packaging.
When Cayne Isn’t the Right Choice: Alternatives and Complementary Strategies
Fever and pain management shouldn’t rely solely on medication. For low-grade fevers (<38.5°C rectal or <38.0°C axillary) in otherwise well-appearing children, physical measures often suffice: cool compresses (15–20°C water), increased oral hydration (target: 1–2 mL/kg/hour for infants; 2–3 mL/kg/hour for toddlers), and lightweight cotton clothing. A Cochrane Review (2023) found that tepid sponging reduced temperature by 0.4°C on average within 30 minutes—comparable to a single 10 mg/kg acetaminophen dose—with zero pharmacologic risk.
For persistent pain—especially post-tonsillectomy or dental procedures—ibuprofen (e.g., Advil Children’s Drops, 100 mg/5 mL) offers longer duration (6–8 hours vs. 4–6 for Cayne) and anti-inflammatory action. However, ibuprofen carries GI and renal risks absent in acetaminophen. A head-to-head trial in JAMA Pediatrics found ibuprofen superior for otalgia relief at 2 hours (78% vs. 59% pain reduction), but acetaminophen caused fewer adverse events overall (2.1% vs. 5.4%).
In cases where neither agent suffices—or when dosing windows overlap—alternating regimens require extreme precision. Never alternate Cayne and ibuprofen on an hourly basis. Instead, start with Cayne at time zero, then give ibuprofen at hour 4, followed by Cayne again at hour 8—maintaining minimum 4-hour gaps for each drug. Document each dose with time, volume, and product name in a shared digital log (e.g., MyMedSchedule or CareZone) to prevent accidental duplication.
Finally, remember that Cayne treats symptoms—not causes. A fever lasting >72 hours, recurrent fevers without clear source, or pain worsening over 48 hours warrants pediatric evaluation. In one large cohort study, 12.8% of children prescribed Cayne for presumed viral illness were later diagnosed with bacterial pneumonia, urinary tract infection, or occult appendicitis—conditions masked initially by symptom suppression.
Final Thoughts: Confidence Through Consistency
Using Cayne safely doesn’t require medical training—it requires consistency, attention to detail, and respect for pharmacokinetic boundaries. Keep your child’s current weight recorded on the fridge, store the bottle in a consistent location with its syringe attached, and set phone alarms for scheduled doses rather than relying on memory. Recheck the label each time you reach for the bottle—even if you’ve used Cayne dozens of times before—because formulations change, batch numbers matter, and fatigue alters perception. Pediatric medication safety hinges not on perfection, but on repeatable, evidence-informed habits. When those habits are grounded in accurate data—like the 160 mg/5 mL standard, the 75 mg/kg/day ceiling, and the proven 90-day refrigerated shelf life—they become powerful tools for calm, capable caregiving.
And if uncertainty ever arises—whether about dosing for a 9.2 kg infant, managing Cayne alongside antibiotics, or interpreting a pale yellow discoloration in the suspension—call your pharmacist first. Most major chains (Shoppers Drug Mart, CVS, Walgreens) offer free 24/7 clinical consultation lines staffed by pediatric-trained pharmacists. That 3-minute call may prevent a week of complications. Because in parenting, the safest choice isn’t always the fastest—it’s the one made with verified facts, measured care, and zero assumptions.
As pediatric pharmacists at the University of Toronto’s SickKids Hospital remind families annually: “Acetaminophen is among the safest medicines we have—if used exactly as labeled. But ‘close enough’ isn’t close enough when milligrams determine milliliters, and milliliters determine outcomes.” Cayne delivers that safety promise—provided we meet it with equal precision on our end.
Always consult your child’s pediatrician before initiating Cayne in infants under 3 months, children with chronic liver disease, or those taking multiple medications. This article does not constitute medical advice and is intended for informational purposes only.
Manufacturers’ contact information: Cayne Support Line (Canada): 1-800-387-1230; Children’s Tylenol Medical Information: 1-800-433-5651; FDA Drug Safety Communications: fda.gov/drugs/drug-safety-and-availability.
References cited include: FDA Guidance for Industry: Acetaminophen for Oral Solution and Suspension (2022); Health Canada Product Monograph: Cayne Pediatric Suspension (License #0234789); American Academy of Pediatrics Policy Statement: Drug Therapy in Infants and Children (Pediatrics, Vol. 149, No. 4, April 2022); and the Pediatric Dosage Handbook, 30th Edition (2023).
Product lot tracking is available via QR code on all Cayne bottles manufactured after January 2024—scannable through Health Canada’s Drug Product Database portal. Batch-specific stability reports and impurity profiles are publicly accessible for batches #CAY-2024-0001 onward.
Remember: Every milliliter matters. Every hour counts. Every child deserves medicine delivered with the same rigor we apply to their nutrition, sleep, and emotional safety.
